EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, Characterization, and Biological Evaluation of Aliphatic‐Substituted Benzimidazole Derivatives: Induction of Apoptosis, Cell Cycle Arrest, and Molecular Docking in Breast Cancer Cells

Murat Keser, Çisil Çamlı Pulat, Harika Atmaca, Hakan Akgün, Canan Albay, Emre Menteşe iD, Hakan Bektaş, Suleyman Ilhan iD

Drug Development Research · 2026

DOI: 10.1002/ddr.70267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2026. Verfasst von Murat Keser und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Medicana International İzmir Hospital, İzmir, Türkiye. Hauptthemen laut MEDLINE: Benzimidazoles, Apoptosis, Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new series of aliphatic‐substituted benzimidazole derivatives was synthesized and structurally characterized to evaluate their potential anticancer activity. Among the synthesized compounds, compound 4 exhibited the most potent cytotoxic effects against MCF‐7 and MDA‐MB‐231 breast cancer cell lines, with IC₅₀ values comparable to those of cisplatin, while displaying lower toxicity toward normal breast epithelial cells (MCF‐10A). Flow cytometric analysis revealed that treatment with compound 4 resulted in significant accumulation of cells in the S phase, indicating inhibition of DNA synthesis and replication. Furthermore, Annexin V/PI double‐staining analysis demonstrated a marked increase in both early and late apoptotic cell populations, confirming the activation of apoptotic pathways. Molecular docking studies supported these experimental findings by revealing strong interactions of compound 4 with key regulatory proteins involved in apoptosis and cell cycle progression, including Bcl‐2, Bcl‐xL, CDK2, and Cyclin E. The compound exhibited the highest binding affinity toward CDK2 (–164.055 kcal/mol), forming hydrogen bonds with critical residues (LEU134, ASP145, GLN131, and LYS33) within the ATP‐binding pocket, suggesting potential inhibition of kinase activity. Interactions with Bcl‐2 and Bcl‐xL occurred within the BH3‐binding grooves, which may impair their anti‐apoptotic functions and promote mitochondrial‐mediated apoptosis. Collectively, the in vitro and in silico results indicate that this newly synthesized benzimidazole derivative exerts its anticancer effects through a dual mechanism involving cell cycle arrest and apoptosis induction. The selective cytotoxicity and multitarget interaction profile of compound 4 highlight its potential as a promising lead compound for the development of novel therapeutic agents against breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesApoptosisAntineoplastic AgentsBreast NeoplasmsCell Cycle CheckpointsHumansMolecular Docking SimulationFemaleMDA-MB-231 CellsCyclin-Dependent Kinase 2MCF-7 CellsStructure-Activity RelationshipCell Line, TumorProto-Oncogene Proteins c-bcl-2bcl-X ProteinCyclin E

Stichwörter der Autor:innen

Bcl‐2Bcl‐xLCDK2aliphatic‐substituted benzimidazoleapoptosisbreast cancercell cycle arrestcytotoxicitymolecular dockingmultitarget anticancer agent

Substanzen

BenzimidazolesAntineoplastic AgentsCyclin-Dependent Kinase 2CDK2 protein, humanProto-Oncogene Proteins c-bcl-2bcl-X ProteinCyclin E

Autor:innen und Institutionen

  • Department of Medical Oncology, Medicana International İzmir Hospital, İzmir, Türkiye.
  • Applied Science Research Center, Manisa Celal Bayar University, Manisa, Türkiye.
  • Department of Biology, Faculty of Engineering and Natural Sciences, Manisa Celal Bayar University, Manisa, Türkiye.
  • Department of Chemistry, Faculty of Science and Art, Giresun University, Giresun, Türkiye.
  • Department of Chemistry, Faculty of Science and Art, Recep Tayyip Erdogan University, Rize, Türkiye.

ORCID-Profile: Emre Menteşe, Suleyman Ilhan

Zitieren

APA

Keser, M., Çamlı Pulat, Ç., Atmaca, H., Akgün, H., Albay, C., Menteşe, E., Bektaş, H., & Ilhan, S. (2026). Synthesis, Characterization, and Biological Evaluation of Aliphatic‐Substituted Benzimidazole Derivatives: Induction of Apoptosis, Cell Cycle Arrest, and Molecular Docking in Breast Cancer Cells. Drug Development Research. https://doi.org/10.1002/ddr.70267

Vancouver

Keser M, Çamlı Pulat Ç, Atmaca H, Akgün H, Albay C, Menteşe E, et al. Synthesis, Characterization, and Biological Evaluation of Aliphatic‐Substituted Benzimidazole Derivatives: Induction of Apoptosis, Cell Cycle Arrest, and Molecular Docking in Breast Cancer Cells. Drug Development Research. 2026. doi:10.1002/ddr.70267

BibTeX
@article{Keser2026,
  author = {Keser, Murat and Çamlı Pulat, Çisil and Atmaca, Harika and Akgün, Hakan and Albay, Canan and Menteşe, Emre and Bektaş, Hakan and Ilhan, Suleyman},
  title = {Synthesis, Characterization, and Biological Evaluation of Aliphatic‐Substituted Benzimidazole Derivatives: Induction of Apoptosis, Cell Cycle Arrest, and Molecular Docking in Breast Cancer Cells},
  journal = {Drug Development Research},
  year = {2026},
  doi = {10.1002/ddr.70267}
}
Kostenlos starten →